Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Medical Research Council (MC_UU_00011/1; MC_UU_00011/6; MC_UU_00011/7; MR/V033867/1)
Diabetes UK (17/0005700)
British Heart Foundation (AA/18/1/34219; CH/F/20/90003)
National Institute of Health (NF-0616-10102)
- License Information
-
More Information
Article History
Received: 2 November 2022
Accepted: 13 March 2023
First Online: 3 April 2023
Declarations
:
: The data collection in UK Biobank was approved by the NHS National Research Ethics Service (ref 11/NW/0382). All data-sets used in this data obtained fully informed consent from participants.
: Not applicable.
: All authors have completed the ICMJE uniform disclosure form at . DAL has received support from Roche Diagnostics and Medtronic Ltd for biomarker research unrelated to this paper. MJG and LACM declare no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.
